We are reporting the result of an investigation in immunodiagnosis of opportunistic fungus infections.
The number of patients who were detected with candidal mannan antigens and antibodies to candida were 8 (75%) and 3 (12.5%) in 24 patients with disseminated candidiasis or infection of the lung. Results of tests by two latex agglutination kits with sera obtained from patients with and without candidiasis recognized that the efficiency was 81.5% in kit A (mannan detection kit from Kyokuto Pharmaceutical Industrial Corporation) and 64.6% in kit B (intracytoplasmic protein detection kit from Ramco Laboratories), respectively.
In 11 cases with aspergilloma, aspergillus antibodies were detected in 10 cases (90.9%)
by CIE and/or ID. All of 6 cases with invasive pulmonary aspergillosis were detected galactomannan antigen by using PASTOREX(R)-Aspergillus, while in 14 cases with clinically suspected aspergillus pneumonia, 3 cases (21.4%) were detected galactomannan antigen.
Results of antigen detection tests in sera obtained from experimentally pulmonary aspergillosis in mice indicated that detection of antigen is very useful for rapid diagnosis of invasive pulmonary aspergillosis.
In 11 cases with cryptococcosis, all cases investigated were detected mannan antigen in sera and/or CSF by LA test kit from Eiken Co., Ltd.
Key words: Immunodiagnosis, Visceral Mycoses, Candidiasis, Aspergillosis, Cryptococcosis, Latex agglutination Opportunistic fungus infections have been recognized as important infectious complication in compromised patients treated with immunosuppressive drugs/anticancer drugs/antibiotics. Especially, systemic infections caused by Candida species and invasive pulmonary aspergillosis and/or cryptococcosis have become a major cause of morbidity and mortality among hospitalized patients1-4).
However, it is difficult to establish an antemorten diagnosis of these infections for several reasons. Namely, The clinical presentation is usually nonspecific and a microbiological diagnosis is often difficult.
From these present states, several techniques for detection on antigen and antibody and/or fungal products5,6) have been used: Counterimmunoelectrophoresis (CIE)7), Enzyme-linked immunosorbent assay (ELISA)8,9), Latex agglutination10-12), biochemical assay and immunoblotting method14) to diagnosis of opportunistic fungal infections in recent years.
In this report, we describe the results of investigation in immunodiagnosis of opportunistic fungus infections, Candidiasis Aspergillosis and Cryptococcosis.
Materials and Methods
Patients and Controls: Total 239 sera and 32 cerebrospinal fluid (CFS) samples obtained from 54 cases with candidiasis, 42 cases with pulmonary aspergillosis including clinical suspected cases, 11 cases with cryptococcosis, 102 patients without mycoses and 30 healthy persons were examined in this study.
Of 17 cases with disseminated candidiasis and 7 cases with pneumonia due to candida, 2 2 cases were diagnosed by histological examinations in autopsies and 2 cases with candidemia were diagnosed by blood cultures and clinical findings included the response against antifungal therapy. In 30 cases with undisseminated candidiasis, a case and five cases were oral candidiasis and candidal esophagitis diagnosed by visual and endoscopical findings, and 3 cases with candiduria were diagnosis by cultural examinations (105/ml<). All of the other case with undisseminated candidiasis were autopsy cases.
In fourty two cases with pulmonary aspergillosis, 11 cases were allergic bronchopulmonary aspergillosis (ABPA), another 11 cases with aspergilloma, 6 cases with invasive pulmonary aspergillosis confirmed diagnosed by demonstration of septate branched hyphae in pulmonary tissue specimens or repeated isolation of Aspergillus fumigatus from sputum with a temperature greater than 38C for more than 6 days and unresponsive to systemic antibacterial agents with presence of pulmonary infiltrates, and 14 cases with clinically suspected aspergillus pneumonia defined as temperature greater than 38C for more than 5 days which were unresponsive to antibacterial agents with no evident etiology.
In 11 cases with cryptococcosis, 5 cases were meningitis and 3 cases were cryptococcoma, and 3 cases were meningitis with pneumonia due to Cryptococcus neoformans. All of cases with cryptococcosis were performed diagnosed by cultural examinations.
Preparation of self-made mannan antigens: Candida albicans serotype A human isolate was used. Yeasts were fractured with glass beads. The resultant material was centrifuged at 10,000Xg for 30min.
The pellected cell wall fragments were then dried in acetone and used for the preparation of mannan. The supernatant crude cytoplasmic material was ultracentrifuged at 100,000Xg for 120min to remove organelles. This supernatant was then extensively dialyzed in distilled water and lyophilized. Mannan was removed by affinity chromatography with concanavalin A-Sepharose 4B.
Experimental pulmonary aspergillosis: Animal models were reported by Kume15) for pulmonary aspergillosis in mice by means of newly devised aerosol exposure apparatus. Namely, after placing 12 mice pretreated with cyclophosphamide and predonisolone in the cages, setting them in the exposure apparatus and sealing it hermetically, we put 18ml of 3.0X108cells/ml of Aspergillus fumigatus (Kuboyama strain) suspended in 0.1% tween 80/physiological saline into a glass nebulizer for feeding with a pressure of 1Kg/cm2 for about 30 minutes. Once again we immediately put 18ml of the conidia suspension into the glass nebulizer, repeating the exposure. After performing the exposure totally for 5 hours, we removed the mouse cages and cleaned the heads of the fixed mice with alcohol-moisture cotton (mice without treatment).
The treated mice with antifungal drug were prepared with inhalation of 500mcg/ml amphotericin B solution for 30 minutes after exposure of conidia suspension totally for 5 hours by using the same exposure apparatus.
Results
The comparison of detection between mannan antigen and antibody in 54 cases with candidiasis are shown in Table 1 . The detection of candida antigen was performed by using Latex agglutination reagents from Kyokuto Pharmaceutical Industrial Corporation (LAKyokuto) and anticandidal antibody was detected by counterimmunoelectrophoresis (CIE) and Immunodiffusion test (ID) by using self-made antigen. The number of patients detected with candidal mannan antigens and anticandidal antibodies were 18 (75.0%) and 3 (12.5%) in 24 cases with disseminated candidiasis or infection of the lung, respectively. While, the number of antigen and antibody positive cases were 4 (13.3%) and 13 (43.3%) in 30 cases with infection of the digestive tract and/or the urinary tract, respectively.
The positive cases of candidal mannan antigen detected by LA-Kyokuto are summarized in Table 2 . by each clinical group.
The No. of positive case in cases with disseminated candidiasis or infection of the lung was 18 cases (75.0%). While, in case with infection of the digestive tract or urinary tract and/or oral cavity, 4 cases (13.3%) were detected with candidal mannan antigens by LA-Kyokuto. In 30 cases with other visceral fungal infections (28 cases of pulmonary aspergillosis including the suspected cases, 10 cases of cryptococcosis, a case of mucormycosis and a case with systemic infection due to Trichosporon beigelii) and cases without mycoses and healthy control, candidal mannan antigens were not detected.
The efficiencies were compared between Kit A, namely, mannan antigen detection kit (LAKyokuto) and Kit B, namely, intracytoplasmic protein antigen detection kit (Cand-Tec) from Ramco Laboratories.
The results of tests by these two candidal antigen detection kits with sera from patients with and without candidiasis are shown in Table 3 .
The sensitivity and the specificity of kit A were 60% and 100%, and those of kit B were 60% and 68.6%.
One hundred percent of patients with visceral candidiasis and 64.5 of patients without candidiasis were diagnosed by kit A correctly. However, in the case of kit B, 62.1% of the cases with candidiasis and 66.7% of cases without candidiasis were predicted. From these results, the efficiency was 81.5% in kit A and 64.6% in kit B.
The comparison between detection of garactomannan antigen and antibody in patients with ABPA, Aspergilloma, invasive pulmonary aspergillosis or clinically suspected aspergillus pneumonia are summarized in Table 4 .
Latex tests for detection of aspergillus galactomannan were performed by using PASTOREX(R)-Aspergillus (sensitivity: 15ng/ml of galactomannan) and CIE and/or ID system were used for detection of aspergillus antibodies by the using self-made antigen obtained from Asper- gillus fumigatus. Galactomannan antigen was not detected in the serum obtained from the case with ABPA or aspergilloma. In 11 cases with ABPA, 4 cases (36.4%) were detected aspergillus antibodies by means of CIE, and aspergillus antibodies were detected in 10 cases (90.9%) of the case with aspergilloma by the CIE and the ID. While, all cases with invasive pulmonary aspergillosis were detected galactomannan antigen without detection of antiaspergillus antibodies. In 14 cases with clinically suspected aspergillus pneumonia, 3 cases (21.4%) and 2 cases (14.3%) were detected galactomannan antigen and antibody, respectively. Fig. 1 demonstrate the changes in the number of viable fungal cells in the lung, the amount of intrapulmonary fungus cells, and the time course changes in the severity of pulmonary lesions which were evaluated from the area of the infected lesions and the number of lesions in the comparison between treated mice and untreated mice.
In the mice treated with AMPH, the number of viable fungal cells in the lung was 3.9X104/ left lung, immediately after the exposure, 3.2 X 104/left lung after 2 hours, 5. 9X103/left lung after 8 hours, 0 after 24 hours and 48 hours, mice demonstrated a mortality rate of 80 to 100%. Table 5 showed the antigen titer detected by using PASTOREX(R)-Aspergillus in sera obtained from experimentally pulmonary aspergillosis in mice. Galactomannan antigen in sera was detected at 48 hours after the exposure of Aspergillus fumigatus.
These results indicate that detection of antigen is very useful for rapid diagnosis of invasive pulmonary aspergillosis.
The results of tests for the detection of Cryptococcal antigen and antibody in sera and CSF from patients with Cryptococcosis are shown in Table 6 . In 11 cases with cryptococcosis, namely 5 cases with meningitis, and 3 cases with meningitis and pneumonia, and 3 cases with pneumonia, mannan antigen was detected in all cases investigated using the LA test kit (from Eiken Co., Ltd.) after protease 
Disccusion
Despite increasing clinical awareness of candida infections, clinical and conventional microbiologic diagnosis remains difficult. Therefore, a number of methods for rapid serologic diagnosis of significant candida infection have been investigated. Detection tests for antibody to candida antigens have been widely studed16), but the diagnostic efficiency of detection of candida antibody remains controversial17). Measurement of candida antigens or metabolites has therefore been attempted5,6, 18, 19) Two latex agglutination kits to detect candida antigen were compared for the diagnostic efficiency in theses studies. We chose a latex agglutination test for detection of antigen because of the simplicity of this method and, therefore, its practicality for widespread application. The efficiency and specificity were 81.5% and 100% in mannan detection kit from Kyokuto Co. , Ltd. (LA-Kyokuto) and 64.6% and 68. 6% in intracytoplasmic protein detection kit from Ramco Lab. (Cand-Tec). These results indicate detection of mannan dissolved from the candida surface and circulating in serum by using LA-Kyokuto has been diagnostically useful. But since some serum samples from disseminated candidiasis were positive only by LA-Kyokuto and some other samples were positive only by Cand-Tec, a combination of another techniques, Cand-Tec, may prove more useful.
We investigated the evaluation of LA test to detect candidal mannan antigen in sera obtained from experimental gastric candidiasis of mice with or without treatment. The result shows good correlation between the change of the titer of mannan antigen and the severity of infections, and gastric lesions healed histopathologically 3 weeks after disappearance of mannan antigen in sera obtained from mice treated with antifungal agent. From these results we emphasize that the antifungal Note ; Latex tests for antigenemia were performed by using the serodirect "Eiken"
(sensitivity: 6.25ng/ml) therapy is necessary for about more 3 weeks since candidal mannan antigen disappeared from sera. Pulmonary aspergillosis, especially invasive pulmonary aspergillosis are being recognized with increasing frequency20,21) Rogers et al22). reported ELISA for detection of aspergillus antigen gave positive and negative predictive values for invasive pulmonary aspergillosis of greater than 95%, demonstrating the value of antigen detection in early diagnosis of invasive pulmonary aspergillus infection. However, ELISA or RIA procedures are not commercially available.
A recent assay system which is technically simpler has been marketed by Diagnostics Pasteur, namely, PASTOREX(R)-Aspergillus. This assay system is based on latex particles coated with rat monoclonal antibody prepared against galactomannan.
Sensitivity of the reagent is 15ng/ml. Dupon et al23). reported sensitivity and specificity of the PASTOREX(R)-Aspergillus was 93.3% and 100% in prospective studies used sera obtained from the patient with or without invasive aspergillosis.
While, Haynes et al24). indicated sensitivity of 94.7% and specificity of 93.2%
in their retrospective studies.
In our own investigation with this new kit, galactomannan antigen was not detected in the serum obtained from the case with ABPA or aspergilloma. While, in all of the 6 cases with invasive pulmonary aspergillosis, galactomannan antigen was detected. In addition, galactomannan antigen in sera obtained from experimental pulmonary aspergillosis in mice by using this kit was detected in early stage of infection. These results indicate PASTOREX(R)-Aspergillus is very useful for rapid diagnosis of invasive pulmonary aspergillosis.
Cryptococcus neof ormans is an encapsulated, yeast-like pathogen with world wide distribution. This fungus is recognized as the etiologic agent of cryptococcosis and most often is manifested as a pulmonary or meningeal infection25). The latex test for cryptococcal antigen detection is one of the most reliable fungal serological tests available to clinicians. Especially it is most useful for the diagnosis used CSF of cryptococcal meningitis, but circulating capsular polysaccharide antigen can sometimes be detected in the serum of patients having other forms of cryptococcosis. In our studies, mannan antigen in the serum by LA test kit (from Eiken Co., Ltd.)26) was detected in all cases with cryptococcosis investigated.
The detection of cryptococcal antigen in serum is, however, some times obscured by the presence of rheumatoid factor (RF) or other interfering substances27). When this occurs, it is difficult to determine whether the serum contains cryptococcal antigen, interference factors, or both. In 1983 Stockman and Roberts 28) used a protease treatment to destroy interfering factors in the LA test, and indicated that protease have enough ability to remove interfering factors. Moreover, protease pretreatment may have released antigen from soluble immune complexes in sera. The LA kit from Eiken dose actually contains the protease pre-treatment procedure, therefore high sensitivity and specificity and/or high antigen titer would be obtained in our investigations.
In 1935, Benham29) divided Cryptococcus neoformans into two serologic sub group. Evans30) later divided it into three serotypes, and Walter and Coffee31) reported a fourth serotype in 1968. These four serotypes, designated as A, B, C and D, are defined by specific rabbit antisera, preabsorbed with strains of the heterologous groups to remove crossreactivity.
While, Shinoda et al.32) have been described the serotype distributions of Cryptococcus neoformans isolated clinical specimens were 87 % for A, 9% for D and 4% for AD, and serotype B and C have not been isolated in Japan. From these results, this LA kit was prepared with antibody immunized by Cryptococcus neof ormans serotype A26). It is natural results (unpublish data) that the antigen titer by using above the LA kit has been recognized higher titer in sera obtained from mice infected with Cryptococcus neoformans serotype A than 
